Tags PFAS Removal
Tag: PFAS Removal
BioLargo's Q3 2025 report shows tech traction in PFAS, Clyra™, and Cellinity™ — but monetization remains elusive post-Pooph® fallout.
BioLargo's Q2 exposes value-chain gaps—regulatory lags, partner dependency, and no clear path from validation to revenue.
BioLargo’s growth hinges on its AEC, Clyra™, and Pooph® innovations, but delays and cash burn turn Q2–Q3 into a critical test for its long-term ambitions.
BioLargo CEO Dennis P. Calvert appointed to the U.S. Environmental Technologies Trade Advisory Committee as company celebrates 80% revenue growth in 2024.
BioLargo, Inc. starts its Lake Stockholm PFAS removal pilot this month with its efficient AEC technology, reducing hazardous waste by over 99% compared to GAC.
BioLargo's recent financials and corporate updates highlight continued growth of its AEC PFAS-removal technology soon to be operational at commercial scale.
The U.S. EPA’s roadmap to regulate and eliminate PFAS in U.S. drinking water supplies will command BioLargo’s AEC technology as the most advanced PFAS removal technology to scale.
